Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism SRD5A1 modulators(Steroid 5 alpha reductase 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chemical and Drug Induced Liver Injury | Preclinical | - | 07 Dec 2022 |





